5 Finnish University Hospitals Up Preparedness with New Technology Reports EpiGuard

EpiGuard reports all five University Hospitals in Finland come together to implement the new isolation and transport system. With EpiShuttles at all hospitals, Finland stands better prepared to face new pandemics or chemical and nuclear threats.

EpiGuard notes as one of the actions to increase Finland’s preparedness, the five university hospital districts jointly procured the so-called EpiShuttles, a Norwegian invention that isolates a contagious patient while being treated.

We are implementing a highly efficient tool to transport patients with highly contagious diseases, or chemical, biological or other contamination necessitating isolation. The single patient isolation and transport unit are designed to provide maximum public safety while allowing critical care and treatment to be performed on the contaminated patient inside. The unit can be used for patient transport through air, land, and sea in collaboration with the Finnish Border Guard and Defence Force units when needed, keeping society safe, Tom Silfvast, Chief Medical Officer at the Preparedness Unit at Helsinki University Hospital, said.

The procurement of the nine EpiShuttles is financed by the Government and steered by the Ministry of Social Affairs and Health. The new equipment will be used in all the areas that the five University Hospitals cover notes EpiGuard.

Ready for the next pandemic

Back in 2018, the WHO made a list of 10 diseases with the potential to cause a public health emergency. On that list was Disease X, a pathogen currently unknown. As it turns out, Disease X was the coronavirus. However, the threat of yet another new pathogen emerging, has never been greater.

With this new technology, we stand better prepared for a new pandemic. Contagious patient logistics are complicated. Finland has a lot of remote areas, and transporting contagious patients fast over long distances, into hospitals for treatment is a severe challenge. Time-consuming disinfection procedures of helicopters, aircraft, and ambulances after each transport threaten capacity. Not knowing what comes next, the EpiShuttle is our best option. We now stand ready to deploy if needed, Sanna Hoppu, Associate Professor and Chief Physician at Tampere University Hospital, said.

Safe transport of contagious patients is essential when handling the epidemic. The Johns Hopkins Center for Health Security in partnership with the World Economic Forum and the Bill and Melinda Gates Foundation recommends such medical countermeasures as the EpiShuttle represents at a “Disease X dummy run”, the so-called Event 201.

Patient transport to where ICU capacity is available has proven to be a crucial piece of the puzzle when handling a pandemic. Only when safe transport is in place can we utilize the full capacity of the entire health care system and ensure treatment for everyone, Ellen Cathrine Andersen, CEO at EpiGuard said.

The WHO R&D Blueprint Special Advisory Group said, “History tells us that it is likely the next big outbreak will be something we have not seen before.” This still goes, and a Disease Y can surface at any time.

The UN Humanitarian Response Depot (UNHRD) holds six EpiShuttles, for the safe transport of contagious patients. Congo was the first place they dispatched, during the Ebola outbreak. UNHRD offers storage at no cost at six strategically located locations near major ports and airports.

EpiGuard notes their EpiShuttles are used by WHO as well as first responders in Germany, Belgium, Denmark, Peru, Ireland, Greece, Norway, and the UK. Also, national air forces like the British, Australian, Canadian, Danish, Norwegian and others are equipped with EpiShuttles. In the private sector, EpiShuttles are a common sight amongst companies like FAI air ambulance, Air Alliance Medflight, DRF Luftrettung, Keewatin Air, Luxembourg Air Rescue, Loganair and others.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

"Receiving this first FDA clearance for our retinal camera is not just a milestone, it's a leap forward in our quest to safeguard the vision of millions," said Dr. Patrick Sauvageau, optometrist, CEO, and co-founder of Zilia. "We're now focused on obtaining De Novo classification for ocular oximetry, a breakthrough biomarker that promises to revolutionize how we diagnose and manage a variety of ocular conditions."
The recent FDA clearances included Brainomix 360 e-CTP and Brainomix 360 e-MRI, both software modules that can support thrombolysis and thrombectomy treatment decisions, particularly for late-window patients who present to hospital more than 6-12 hours after stroke onset.
IONIC Health’s 510(k)-pending nCommand Lite technology is designed to include vendor-agnostic remote scanning capabilities. This strategic collaboration’s goal is to enable GE HealthCare to provide a multi-vendor, multi-modality remote scanning solution to healthcare systems and patients around the globe.
Silmitasertib works by inhibiting CK2 protein kinase, which have implicated in regulation of several signaling pathways that are important for innate immune responses. CK2 modulates inflammatory pathways, including NF-κB, PI3K–Akt–mTOR, and JAK–STAT.
"This is the culmination of years of research and development to deliver a medical device that helps improve the lives of patients suffering from spinal stenosis. Our recent move to larger premises in the Research Park at FAU will allow us to train our surgical and distribution partners to become increasingly competitive in the spinal implant device market,” said Peter Harris, founder and CEO of FloSpine.

By using this website you agree to accept Medical Device News Magazine Privacy Policy